Immunovant Inc IMVT

NAS: IMVT | ISIN: US45258J1025   15/11/2024
26,63 USD (-5,06%)
(-5,06%)   15/11/2024

13 oktober 2023 · Thinking about trading options or stock in Dollar General, Immunovant, Camber Energy, Advanced Micro Devices, or Novo Nordisk? · Persbericht

28 september 2023 · Thinking about buying stock in Seelos Therapeutics, West Red Lake Gold Mines, Immunovant, MSP Recovery, or Transcode Therapeutics? · Persbericht

27 september 2023 · Thinking about buying stock in American Lithium, Avalo Therapeutics, Seelos Therapeutics, Rivian Automotive, or Immunovant? · Persbericht

26 september 2023 · Thinking about trading options or stock in Immunovant, Manchester United, Philip Morris International, Vale SA, or Novo Nordisk? · Persbericht

5 oktober 2022 · R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing · Persbericht

19 april 2021 · APRIL 20, 2021, IMVT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Immunovant, Inc. · Persbericht

19 maart 2021 · Pomerantz Law Firm Announces the Filing of a Class Action against Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation and Certain Officers - IMVT; HSACU; HSAC; and HSACW · Persbericht

18 maart 2021 · SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class Action Lawsuit and Upcoming Deadline - IMVT; HSACU; HSAC; and HSACW · Persbericht

18 maart 2021 · IMVT SHAREHOLDER LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Immunovant, Inc. · Persbericht

17 maart 2021 · INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm · Persbericht

12 maart 2021 · SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class Action Lawsuit and Upcoming Deadline - IMVT; HSACU; HSAC; and HSACW · Persbericht

9 maart 2021 · IMVT BREAKING NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - IMVT, HSACU, HSAC, HSACW · Persbericht

3 maart 2021 · INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm · Persbericht

3 maart 2021 · SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class Action Lawsuit and Upcoming Deadline - IMVT; HSACU; HSAC; and HSACW · Persbericht

27 februari 2021 · ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - IMVT, HSACU, HSAC, HSACW · Persbericht

25 februari 2021 · IMVT INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Immunovant, Inc. · Persbericht

23 februari 2021 · IMVT Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Immunovant, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm · Persbericht

20 februari 2021 · Pomerantz Law Firm Announces the Filing of a Class Action against Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation and Certain Officers - IMVT; HSACU; HSAC; and HSACW · Persbericht

10 februari 2021 · SHAREHOLDER INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Immunovant, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm · Persbericht

5 februari 2021 · SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunovant, Inc. - IMVT · Persbericht

Mijn selecties